Westmount Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Sell
10,185
-182
-2% -$10.5K 0.13% 133
2026
Q1
$629K Buy
10,367
+11
+0.1% +$641 0.15% 119
2025
Q4
$559K Sell
10,356
-52
-0.5% -$2.5K 0.14% 122
2025
Q3
$494K Buy
10,408
+13
+0.1% +$607 0.13% 137
2025
Q2
$481K Buy
10,395
+11
+0.1% +$540 0.13% 130
2025
Q1
$633K Buy
10,384
+9
+0.1% +$525 0.19% 107
2024
Q4
$587K Buy
10,375
+10
+0.1% +$559 0.18% 105
2024
Q3
$536K Sell
10,365
-100
-1% -$4.69K 0.16% 109
2024
Q2
$432K Buy
10,465
+123
+1% +$5.5K 0.14% 123
2024
Q1
$561K Sell
10,342
-190
-2% -$9.68K 0.2% 104
2023
Q4
$540K Sell
10,532
-1,254
-11% -$65.8K 0.22% 98
2023
Q3
$684K Buy
11,786
+679
+6% +$41.6K 0.3% 79
2023
Q2
$710K Buy
11,107
+277
+3% +$18.6K 0.31% 69
2023
Q1
$751K Buy
10,830
+8
+0.1% +$564 0.35% 66
2022
Q4
$779K Buy
+10,822
New +$816K 0.4% 55

Other funds holding BMY